Literature DB >> 16981684

Kinetics and thermodynamics of amyloid fibril assembly.

Ronald Wetzel1.   

Abstract

With some exceptions, amyloids appear to be accidental aggregated structures whose formation was not selected for in molecular evolution. Despite this, amyloid fibrils are in many respects surprisingly well-behaved molecules. For example, Huntington's disease-related polyglutamine sequences aggregate via a relatively simple nucleated growth polymerization mechanism. In addition, the Alzheimer's plaque protein Abeta has been shown to undergo reversible amyloid fibril formation to a position of dynamic equilibrium such that reaction thermodynamics can be quantified. Studies of these well-behaved amyloid systems are allowing us to peer more deeply into the process and products of off-pathway misfolding and aggregation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16981684     DOI: 10.1021/ar050069h

Source DB:  PubMed          Journal:  Acc Chem Res        ISSN: 0001-4842            Impact factor:   22.384


  95 in total

1.  Dynamic imaging by fluorescence correlation spectroscopy identifies diverse populations of polyglutamine oligomers formed in vivo.

Authors:  Monica Beam; M Catarina Silva; Richard I Morimoto
Journal:  J Biol Chem       Date:  2012-06-05       Impact factor: 5.157

2.  Dissecting the kinetic process of amyloid fiber formation through asymptotic analysis.

Authors:  Liu Hong; Xianghong Qi; Yang Zhang
Journal:  J Phys Chem B       Date:  2011-12-13       Impact factor: 2.991

3.  A variational model for oligomer-formation process of GNNQQNY peptide from yeast prion protein Sup35.

Authors:  Xianghong Qi; Liu Hong; Yang Zhang
Journal:  Biophys J       Date:  2012-02-07       Impact factor: 4.033

4.  An equilibrium model for linear and closed-loop amyloid fibril formation.

Authors:  Shuo Yang; Michael D W Griffin; Katrina J Binger; Peter Schuck; Geoffrey J Howlett
Journal:  J Mol Biol       Date:  2012-02-24       Impact factor: 5.469

5.  Human cytomegalovirus UL97 kinase prevents the deposition of mutant protein aggregates in cellular models of Huntington's disease and ataxia.

Authors:  Cristy Tower; Lianwu Fu; Rachel Gill; Mark Prichard; Mathieu Lesort; Elizabeth Sztul
Journal:  Neurobiol Dis       Date:  2010-08-20       Impact factor: 5.996

6.  Mass spectrometry and the amyloid problem--how far can we go in the gas phase?

Authors:  Alison E Ashcroft
Journal:  J Am Soc Mass Spectrom       Date:  2010-03-09       Impact factor: 3.109

7.  Comparison of amyloid fibril formation by two closely related immunoglobulin light chain variable domains.

Authors:  Douglas J Martin; Marina Ramirez-Alvarado
Journal:  Amyloid       Date:  2010-09       Impact factor: 7.141

8.  What Can the Kinetics of Amyloid Fibril Formation Tell about Off-pathway Aggregation?

Authors:  Rosa Crespo; Eva Villar-Alvarez; Pablo Taboada; Fernando A Rocha; Ana M Damas; Pedro M Martins
Journal:  J Biol Chem       Date:  2015-11-24       Impact factor: 5.157

Review 9.  Molecular Signaling Mechanisms of Natural and Synthetic Retinoids for Inhibition of Pathogenesis in Alzheimer's Disease.

Authors:  Mrinmay Chakrabarti; Alexander J McDonald; J Will Reed; Melissa A Moss; Bhaskar C Das; Swapan K Ray
Journal:  J Alzheimers Dis       Date:  2016       Impact factor: 4.472

10.  Detection and analysis of protein aggregation with confocal single molecule fluorescence spectroscopy.

Authors:  Frank Hillger; Daniel Nettels; Simone Dorsch; Benjamin Schuler
Journal:  J Fluoresc       Date:  2007-04-20       Impact factor: 2.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.